27.06.2013 • NewsNovasepMichel SpagnolPeople

Michael Spagnol New Novasep President and CEO

Michel Spagnol has been appointed president and CEO of Novasep.
Michel Spagnol has been appointed president and CEO of Novasep.

Michel Spagnol has been appointed president and CEO of Novasep; he succeeds Patrick Glaser. Spagnol was most recently president and chief technology officer of Shasun; previously, he held several positions at Rhodia, including sales and marketing VP of Rhodia Pharma Solutions.

Novasep has also recently announced several investments in France and China. The company plans to build the world's largest build the world's largest chromatography plant dedicated to the pharmaceutical industry in Le Mans and is expanding its manufacturing anti-cancer therapies capabilities in Shanghai to serve the Asian market.

"Novasep is on the right track for continued growth and expansion with promising projects which will enable us to continue delivering value-added solutions for our global customers," Spagnol said.

 

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.